Adam David DeVore, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Duke Clinical Research Institute 200 Morris Street, #6318, Durham, NC 27701
Phone (919) 668-8788
Email address adam.devore@duke.edu

Adam D. DeVore, MD, MHS

Dr. DeVore is a cardiologist and Assistant Professor of Medicine in the Department of Medicine, Division of Cardiology, at Duke University School of Medicine. His clinical interests include caring for patients and families with heart failure, including those with left ventricular assist devices and heart transplants. He is involved in and leads multiple large studies of patients with heart failure at both Duke University Medical Center and the Duke Clinical Research Institute. He currently serves as the assistant director of the Duke Heart Transplant program and the medical director for the Heart Failure Research Cluster.

He attended medical school at the University of Chicago Pritzker School of Medicine and completed internal medicine residency at Brigham and Women’s Hospital. He then pursued cardiology training at Duke University and solidified his interests in clinical research and heart failure. He completed a research fellowship at the Duke Clinical Research Institute and a Masters of Health Sciences in Clinical Research before completing an advanced heart failure fellowship at Duke University.

The overarching goals of his research are to advance the current understanding of heart failure through clinical trials as well as develop an evidence base for implementation strategies that addresses the gap between heart failure trial results and clinical practice. For example, he has served on the Steering Committees for large clinical trials, including PIONEER-HF and SPIRRIT-HFpEF. Dr. DeVore also published the first clinical trial conducted within the American Heart Association’s Get With The Guidelines-Heart Failure program, a registry-based cluster randomized trial of quality improvement interventions. He is also the principal investigator for CONNECT-HF, a large-scale, pragmatic, cluster-randomized trial at 161 sites in the US evaluating heart failure quality improvement initiatives. Outside of his work on heart failure, Dr. DeVore is  married with 4 children and spends his time corralling them all and coaching Little League baseball.

 

 

Education and Training

  • Fellowship in Advanced Heart Failure, Medicine, Duke University School of Medicine, 2015 - 2016
  • Fellowship in Clinical Research, DCRI, Duke University School of Medicine, 2013 - 2015
  • Fellowship in Cardiovascular Medicine, Medicine, Duke University School of Medicine, 2011 - 2013
  • Internal Medicine Residency, Brigham and Women's Hospital, 2007 - 2010
  • M.D., The University of Chicago, 2007

Publications

Nanni, Alexis N., Matthew Harris, Mara Watson, Zidanyue Yang, Hui-Jie Lee, Adam D. DeVore, and James B. Henderson. “Association of Tacrolimus Time-to-Therapeutic Range on Renal Dysfunction and Acute Cellular Rejection after Orthotopic Heart Transplantation in a high use Basiliximab Population.” Clin Transplant, November 19, 2021, e14542. https://doi.org/10.1111/ctr.14542.

PMID
34797576
Full Text

DeVore, Adam D., Claude Larry Hill, Laine E. Thomas, Nancy M. Albert, Javed Butler, J Herbert Patterson, Adrian F. Hernandez, et al. “Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT-HF risk model.” Esc Heart Fail, November 17, 2021. https://doi.org/10.1002/ehf2.13709.

PMID
34791838
Full Text

Mann, Douglas L., Michael M. Givertz, Justin M. Vader, Randall C. Starling, Palak Shah, Steven E. McNulty, Kevin J. Anstrom, et al. “Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.” Jama Cardiol, November 3, 2021. https://doi.org/10.1001/jamacardio.2021.4567.

PMID
34730769
Full Text

Khan, Muhammad Shahzeb, Stephen J. Greene, Anne S. Hellkamp, Adam D. DeVore, Xian Shen, Nancy M. Albert, J Herbert Patterson, et al. “Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.” Circ Heart Fail 14, no. 11 (November 2021): e008351. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008351.

PMID
34674536
Full Text

Breathett, Khadijah K., Haolin Xu, Nancy K. Sweitzer, Elizabeth Calhoun, Roland A. Matsouaka, Clyde W. Yancy, Gregg C. Fonarow, Adam D. DeVore, Deepak L. Bhatt, and Pamela N. Peterson. “Is the Affordable Care Act Medicaid Expansion Associated with Receipt of Heart Failure Guideline-Directed Medical Therapy By Race and Ethnicity?” American Heart Journal, November 2021. https://doi.org/10.1016/j.ahj.2021.11.011.

Full Text

Tran, Andy T., Gregg C. Fonarow, Suzanne V. Arnold, Philip G. Jones, Laine E. Thomas, C Larry Hill, Adam D. DeVore, Javed Butler, Nancy M. Albert, and John A. Spertus. “Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry.” Circ Cardiovasc Qual Outcomes 14, no. 10 (October 2021): e008072. https://doi.org/10.1161/CIRCOUTCOMES.121.008072.

PMID
34615366
Full Text

Carnicelli, Anthony P., Robert Clare, Paul Hofmann, Karen Chiswell, Adam D. DeVore, Sreekanth Vemulapalli, G Michael Felker, Phil Sarocco, and Robert J. Mentz. “Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event.” In J Am Heart Assoc, 10:e021276, 2021. https://doi.org/10.1161/JAHA.120.021276.

PMID
34472362
Full Text

Gilotra, Nisha A., Adam D. DeVore, Thomas J. Povsic, Allison G. Hays, Virginia S. Hahn, Tolu A. Agunbiade, Allison DeLong, et al. “Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure.” Circ Heart Fail 14, no. 9 (September 2021): e008236. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008236.

PMID
34461742
Full Text

Pages